Skip to main content

NovoSeven® RT:

Experience where it matters.

Here’s why NovoSeven® RT may be right for you.

Here’s why it may be right for you:

Controlling bleeds, whenever they happen. NovoSeven® RT is proven effective in controlling bleeding episodes, and preventing bleeds during surgery, in adults and children across 4 indicated disorders.


Room temperature stable and travel ready. NovoSeven® RT requires no refrigeration. After mixing, you may keep it in the vial for up to 3 hours.a

aNovoSeven® RT should be stored between 36°F and 77°F.
For complete storage instructions, please see the Prescribing Information.


Speed when it’s needed. Fast to mix with our MixPro® device, fast to infuse, and fast to control bleeds.b  

bAdminister as a slow bolus injection over 2-5 minutes, depending on the dose administered.


NovoSeven® RT is committed to your experience. More than 30 years of research and long-term clinical experience.c  

cCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.


Here’s why it may be right for you:

Controlling bleeds, whenever they happen. NovoSeven® RT is proven effective in controlling bleeding episodes, and preventing bleeds during surgery, in adults and children across 4 indicated disorders.


Room temperature stable and travel ready. NovoSeven® RT requires no refrigeration. After mixing, you may keep it in the vial for up to 3 hours.a

aNovoSeven® RT should be stored between 36°F and 77°F.
For complete storage instructions, please see the Prescribing Information.


Speed when it’s needed. Fast to mix with our MixPro® device, fast to infuse, and fast to control bleeds.b  

bAdminister as a slow bolus injection over 2-5 minutes, depending on the dose administered.


NovoSeven® RT is committed to your experience. More than 30 years of research and long-term clinical experience.c  

cCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.

Committed to leadership in research and treatment.

NovoSeven® RT has a long history of helping people control their bleeds. Over 30 years of research is behind this treatment,d and today, we continue our commitment to finding new ways to help people with bleeding disorders.

dCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.

Selected Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT

What is NovoSeven® RT?

NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness

What should I tell my healthcare provider before using NovoSeven® RT?

  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
    • congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
    • are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
    • history of heart or blood vessel diseases
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies

What are the possible side effects of NovoSeven® RT?

  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction

Please click here for Prescribing Information